Stockscreener 앱 받기
1.49
6.28%
-0.0999
시간 외 거래:
1.55
0.06
+4.03%
전일 마감가:
$1.5899
열려 있는:
$1.55
하루 거래량:
11,452
Relative Volume:
0.80
시가총액:
$4.60M
수익:
$4.33M
순이익/손실:
$-4.17M
주가수익비율:
-0.9965
EPS:
-1.4953
순현금흐름:
$-3.19M
1주 성능:
-5.99%
1개월 성능:
-15.34%
6개월 성능:
-37.26%
1년 성능:
-54.01%
1일 변동 폭
$1.465
$1.57
1주일 범위
$1.465
$1.65
52주 변동 폭
$1.465
$4.60
Biomerica Inc Stock (BMRA) Company Profile
명칭
Biomerica Inc
전화
(949) 379-2875
주소
17571 VON KARMAN AVENUE, IRVINE, CA
Compare BMRA vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BMRA
Biomerica Inc
|
1.49 | 5.01M | 4.33M | -4.17M | -3.19M | -1.4953 |
ABT
Abbott Laboratories
|
105.74 | 182.00B | 46.59B | 5.41B | 7.38B | 3.0938 |
SYK
Stryker Corp
|
325.74 | 129.09B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
85.40 | 107.81B | 36.36B | 4.84B | 5.43B | 3.7261 |
BSX
Boston Scientific Corp
|
46.73 | 67.64B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.03 | 47.81B | 6.30B | 1.07B | 1.09B | 1.8406 |
Biomerica Inc Stock (BMRA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2020-11-10 | 개시 | Colliers Securities | Buy |
| 2018-01-04 | 개시 | B. Riley FBR, Inc. | Buy |
Biomerica Inc 주식(BMRA)의 최신 뉴스
BMRA|Biomerica Inc|Price:1.620|Chg%:+0.035 - TradingKey
Biomerica Inc (BMRA) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Biomerica Inc (BMRA) Income Statement - TradingKey
Biomerica Inc (BMRA) Institutional Confidence - TradingKey
Biomerica Inc (BMRA) Valuation: PE, PB & Fair Value Analysis - TradingKey
Biomerica Inc (BMRA) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Biomerica Inc (BMRA) Balance Sheet - TradingKey
Biomerica, Inc. Revenue Breakdown – NASDAQ:BMRA - TradingView
Biomerica Inc (BMRA) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
BMRA Q2 2026 Earnings: Pre-Revenue Diagnostics Firm Reports $0.44 Loss Per Share as Stock Holds Steady - dars.gov.et
BMRABiomerica Inc Short Interest - Finviz
Biomerica Inc. (BMRA) Q2 2026 Earnings: Negative EPS as Company Continues Operational FocusBanking Earnings Report - dars.gov.et
Price to sales forward of Biomerica, Inc. – NASDAQ:BMRA - TradingView
Enterprise value to EBITDA forward of Biomerica, Inc. – NASDAQ:BMRA - TradingView
Price to earnings forward of Biomerica, Inc. – NASDAQ:BMRA - TradingView
Biomerica Inc (BMRA) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Biomerica Inc (BMRA) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Biomerica | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plansmoomoo - Moomoo
BMRA Q1 2026 Earnings: Net Loss Reported Amid Operational ChallengesFree Cash Flow Trends - dars.gov.et
Biomerica Inc (BMRA) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Biomerica Inc (BMRA) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Biomerica (BMRA) Slips Slightly to $2.05; Near Key Support Amid Quiet TradingDark Pool Volume - newsline.com
Biomerica (BMRA) Edges Lower, Testing Key Support at $1.95ETF Liquidity - newsline.com
Biomerica (BMRA) Edges Higher as Stock Holds Above Key Support LevelIV Contraction - newsline.com
BMRA Q1 2026 Earnings: Net Loss of $0.44 per Share; Stock Declines 0.92%Analyst Consensus Shift - newsline.com
Biomerica (BMRA) Slides Slightly as Stock Approaches Key Support LevelIceberg Order - newsline.com
Biomerica (BMRA) Q1 2026 Earnings: Narrowing Loss Amid Ongoing Operational ChallengesReturn On Capital - newsline.com
Biomerica, Inc. Announces $500,000 Securities Purchase Agreement and Secured Promissory Note – Form 8-K Filing, May 29, 2026 – Minichart - Minichart
Biomerica Enters Related-Party Deal to Boost Liquidity - TipRanks
Biomerica to Sell 6% Diagnosis Stake for $500,000; Issues 8% Note Pending Transfer - TradingView
Biomerica (BMRA) sells 6% Diagnosis S.A. stake to CEO-affiliated buyers - Stock Titan
Biomerica Inc. (BMRA) Sees Modest Gain as Shares Test Key ResistanceDip Buy Trade - newsline.com
BMRA Q1 2026 Earnings: Operating Loss Widens to $0.44 per Share as Pre-Revenue Biotech Advances Pipeline - newsline.com
Biomerica secures USD 1.75M contract for IVD diagnostic development - Medical Buyer
BMRA Stock Price, Quote & Chart | BIOMERICA INC (NASDAQ:BMRA) - ChartMill
Biomerica Inc. Awarded $1.75 Million Contract for IVD Product Development - geneonline.com
Biomerica (BMRA) Secures Master Services Agreement for Diagnosti - GuruFocus
Biomerica Inc. (BMRA) Holds Near Support Amid Modest PullbackBeta Neutral Pair - The Legal Advocate
Biomerica Wins $1.75M Contract to Develop Diagnostic Tests - Orange County Business Journal
Biomerica signs contract development deal worth over $1.75M By Investing.com - Investing.com Canada
Biomerica lands $1.75 million CDMO master services agreement for IVD diagnostic development - marketscreener.com
Biomerica signs contract development deal worth over $1.75M - Investing.com
Biomerica Lands a $1.75 Million CDMO Master Services Agreement for IVD Diagnostic Development - The Manila Times
Undisclosed $1.75M lab deal taps Biomerica’s diagnostic test expertise - Stock Titan
BMRA Q1 2026 Earnings: Loss of $0.44 Per Share Amid No Revenue DisclosureEarnings Preview - dars.gov.et
Biomerica Q1 2026 Earnings: Net Loss of $0.44 Per Share Amid Lack of Revenue DisclosureManagement Guidance Update - The Legal Advocate
Biomerica Inc. (BMRA) Q1 2026 Earnings: Negative EPS Persists Amid Pre-Revenue StageEarnings Season Review - The Legal Advocate
BMRA Q1 2026 Earnings: Biomerica Reports Net Loss of $0.44 Per Share Amid Ongoing Development Efforts - Newser
Biomerica Inc (BMRA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.04%
11.95%
자본화:
|
볼륨(24시간):